Literature DB >> 18606672

SOCS1 regulates CCR7 expression and migration of CD4+ T cells into peripheral tissues.

Cheng-Rong Yu1, Rashid M Mahdi, Xuebin Liu, Allen Zhang, Tetsuji Naka, Tadamitsu Kishimoto, Charles E Egwuagu.   

Abstract

Suppressors of cytokine signaling (SOCS) proteins control many aspects of lymphocyte function through regulation of STAT pathways. SOCS1-deficient mice develop severe skin and eye diseases that result from massive infiltration of inflammatory cells into these tissues. In this study, we have used SOCS1-, STAT1-, or STAT6-deficient mice, as well as, T cells with stable overexpression or deletion of SOCS1, to examine whether SOCS1 is involved in regulating lymphocyte trafficking to peripheral tissues. We show that SOCS1-deficient mice have increased numbers of T cells with characteristics of effector memory cells and expression of CCR7, a protein that promotes retention of T cells in lymphoid tissues, is markedly reduced in these cells. The decrease in CCR7 expression correlates with hyperactivation of STAT6, suggesting that aberrant recruitment of T cells into SOCS1-deficient mouse skin or eye results from abrogation of negative feedback regulation of STAT6 activation and CCR7 expression. Consistent with in vivo regulation of CCR7 expression and lymphocyte migration by SOCS1, forced overexpression of SOCS1 in T cells up-regulates CCR7 expression and enhances chemotaxis toward CCL19 or CCL21. CCR6 and CXCR3 are also up-regulated on SOCS1-deficient T cells and in situ analysis of the cornea or retina further reveal that these cells may mediate the chronic skin and eye inflammation through recruitment of Th1 and Th17 cells into these tissues. Collectively, these results suggest that SOCS1 regulates steady-state levels of chemokine receptors through its inhibitory effects on STAT pathways and this may underscore its role in regulating recruitment and retention of effector cells into nonlymphoid tissues.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18606672      PMCID: PMC2535918          DOI: 10.4049/jimmunol.181.2.1190

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  34 in total

1.  STAT4/6-dependent differential regulation of chemokine receptors.

Authors:  Soon Ha Kim; Kurt V Gunst; N Sarvetnick
Journal:  Clin Immunol       Date:  2006-01-18       Impact factor: 3.969

2.  SOCS up-regulation mobilizes autologous stem cells through CXCR4 blockade.

Authors:  Oscar M Pello; María del Carmen Moreno-Ortiz; José Miguel Rodríguez-Frade; Laura Martínez-Muñoz; Daniel Lucas; Lucio Gómez; Pilar Lucas; Enrique Samper; Miguel Aracil; Carlos Martínez; Antonio Bernad; Mario Mellado
Journal:  Blood       Date:  2006-08-15       Impact factor: 22.113

3.  Interferon consensus sequence-binding protein is constitutively expressed and differentially regulated in the ocular lens.

Authors:  W Li; C N Nagineni; H Ge; B Efiok; A B Chepelinsky; C E Egwuagu
Journal:  J Biol Chem       Date:  1999-04-02       Impact factor: 5.157

4.  SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine.

Authors:  W S Alexander; R Starr; J E Fenner; C L Scott; E Handman; N S Sprigg; J E Corbin; A L Cornish; R Darwiche; C M Owczarek; T W Kay; N A Nicola; P J Hertzog; D Metcalf; D J Hilton
Journal:  Cell       Date:  1999-09-03       Impact factor: 41.582

5.  SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality.

Authors:  J C Marine; D J Topham; C McKay; D Wang; E Parganas; D Stravopodis; A Yoshimura; J N Ihle
Journal:  Cell       Date:  1999-09-03       Impact factor: 41.582

6.  Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis.

Authors:  Yan Zheng; Dimitry M Danilenko; Patricia Valdez; Ian Kasman; Jeffrey Eastham-Anderson; Jianfeng Wu; Wenjun Ouyang
Journal:  Nature       Date:  2006-12-24       Impact factor: 49.962

7.  Identification of a conserved lipopolysaccharide-plus-interleukin-4-responsive element located at the promoter of germ line epsilon transcripts.

Authors:  P Rothman; S C Li; B Gorham; L Glimcher; F Alt; M Boothby
Journal:  Mol Cell Biol       Date:  1991-11       Impact factor: 4.272

8.  IFN-gamma increases the severity and accelerates the onset of experimental autoimmune uveitis in transgenic rats.

Authors:  C E Egwuagu; J Sztein; R M Mahdi; W Li; C Chao-Chan; J A Smith; P Charukamnoetkanok; A B Chepelinsky
Journal:  J Immunol       Date:  1999-01-01       Impact factor: 5.422

9.  Cutting edge: SOCS-1 is a potent inhibitor of IL-4 signal transduction.

Authors:  J A Losman; X P Chen; D Hilton; P Rothman
Journal:  J Immunol       Date:  1999-04-01       Impact factor: 5.422

10.  Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene.

Authors:  K Shimoda; J van Deursen; M Y Sangster; S R Sarawar; R T Carson; R A Tripp; C Chu; F W Quelle; T Nosaka; D A Vignali; P C Doherty; G Grosveld; W E Paul; J N Ihle
Journal:  Nature       Date:  1996-04-18       Impact factor: 49.962

View more
  10 in total

1.  A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease.

Authors:  Mark A Schroeder; H Jean Khoury; Madan Jagasia; Haris Ali; Gary J Schiller; Karl Staser; Jaebok Choi; Leah Gehrs; Michael C Arbushites; Ying Yan; Peter Langmuir; Nithya Srinivas; Michael Pratta; Miguel-Angel Perales; Yi-Bin Chen; Gabrielle Meyers; John F DiPersio
Journal:  Blood Adv       Date:  2020-04-28

2.  Suppressor of cytokine signaling-1 (SOCS1) inhibits lymphocyte recruitment into the retina and protects SOCS1 transgenic rats and mice from ocular inflammation.

Authors:  Cheng-Rong Yu; Rashid R Mahdi; Hyun-Mee Oh; Ahjoku Amadi-Obi; Grace Levy-Clarke; Jenna Burton; Amarachi Eseonu; Yongjun Lee; Chi-Chao Chan; Charles E Egwuagu
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-01       Impact factor: 4.799

3.  Suppressor of cytokine signaling 1 (SOCS1) mitigates anterior uveitis and confers protection against ocular HSV-1 infection.

Authors:  Cheng-Rong Yu; Kozaburo Hayashi; Yun Sang Lee; Rashid M Mahdi; De Fen Shen; Chi-Chao Chan; Charles E Egwuagu
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

Review 4.  The chemokine receptor CCR7 expressed by dendritic cells: a key player in corneal and ocular surface inflammation.

Authors:  Daniel R Saban
Journal:  Ocul Surf       Date:  2013-12-31       Impact factor: 5.033

5.  Reduced dietary omega-6 to omega-3 fatty acid ratio and 12/15-lipoxygenase deficiency are protective against chronic high fat diet-induced steatohepatitis.

Authors:  Milos Lazic; Maria Eugenia Inzaugarat; Davide Povero; Iris C Zhao; Mark Chen; Madlena Nalbandian; Yury I Miller; Alejandra C Cherñavsky; Ariel E Feldstein; Dorothy D Sears
Journal:  PLoS One       Date:  2014-09-24       Impact factor: 3.240

6.  C/EBPδ drives interactions between human MAIT cells and endothelial cells that are important for extravasation.

Authors:  Chang Hoon Lee; Hongwei H Zhang; Satya P Singh; Lily Koo; Juraj Kabat; Hsinyi Tsang; Tej Pratap Singh; Joshua M Farber
Journal:  Elife       Date:  2018-02-22       Impact factor: 8.140

Review 7.  SOCS and Herpesviruses, With Emphasis on Cytomegalovirus Retinitis.

Authors:  Christine I Alston; Richard D Dix
Journal:  Front Immunol       Date:  2019-04-11       Impact factor: 7.561

8.  Granulocyte macrophage-colony stimulating factor: A key modulator of renal mononuclear phagocyte plasticity.

Authors:  Katie J Mylonas; Jennifer Anderson; Tara A Sheldrake; Emily E Hesketh; James A Richards; David A Ferenbach; David C Kluth; John Savill; Jeremy Hughes
Journal:  Immunobiology       Date:  2018-11-02       Impact factor: 3.144

9.  Multiparameter phospho-flow analysis of lymphocytes in early rheumatoid arthritis: implications for diagnosis and monitoring drug therapy.

Authors:  Carole L Galligan; Janet C Siebert; Katherine A Siminovitch; Edward C Keystone; Vivian Bykerk; Omar D Perez; Eleanor N Fish
Journal:  PLoS One       Date:  2009-08-20       Impact factor: 3.240

10.  CC-chemokine receptor 7 and its ligand CCL19 promote mitral valve interstitial cell migration and repair.

Authors:  Xiaozhi Wang; Liang Wang; Liping Miao; Rong Zhao; Yanhu Wu; Xiangqing Kong
Journal:  J Biomed Res       Date:  2015-09-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.